Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67.6M
-
Number of holders
-
321
-
Total 13F shares, excl. options
-
61.4M
-
Shares change
-
+2.2M
-
Total reported value, excl. options
-
$3.64B
-
Value change
-
-$76.7M
-
Put/Call ratio
-
0.31
-
Number of buys
-
178
-
Number of sells
-
-180
-
Price
-
$59.19
Significant Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q2 2022
412 filings reported holding TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share as of Q2 2022.
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) has 321 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61.4M shares
of 67.6M outstanding shares and own 90.89% of the company stock.
Largest 10 shareholders include FMR LLC (6.47M shares), VANGUARD GROUP INC (6.37M shares), BlackRock Inc. (6.34M shares), Capital World Investors (2.86M shares), Champlain Investment Partners, LLC (2.64M shares), Invesco Ltd. (2.17M shares), STATE STREET CORP (1.72M shares), BROWN CAPITAL MANAGEMENT LLC (1.69M shares), ALLIANCEBERNSTEIN L.P. (1.35M shares), and Bellevue Group AG (1.32M shares).
This table shows the top 321 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.